ABOUT SERO
Translating Scientific Discovery into Targeted Therapeutics
OUR TEAM
Backed by Breakthrough Science and Leaders in the Field
Sero’s science is built on world-class research in GPCR biology, mechanobiology, and translational vascular medicine.
Our founding team brings together experts from Vanderbilt University with deep experience in drug discovery, immunology, and clinical development.
Craig Lindsley, PhD
University Professor of Pharmacology, Biochemistry, and Chemistry
William K. Warren, Jr. Chair in Medicine
Executive Director, Warren Center for Neuroscience Drug Discovery
David Merryman, PhD
Walters Family Professor
Professor of Biomedical Engineering, Pharmacology, Medicine, and Pediatrics
SCIENTIFIC ADVISORS
Bryan Roth, MD, PhD, is a professor of pharmacology at UNC Chapel Hill and a leading expert in GPCR biology and drug discovery, known for developing chemogenetic tools like DREADDs. His work has advanced the understanding of neuropsychiatric drug mechanisms and off-target effects.
Jorg Distler, MD, PhD, is a clinical pharmacologist and researcher specializing in translational medicine and early-phase drug development, with a focus on immunology and inflammatory diseases. He has held leadership roles in academic and pharmaceutical settings, bridging bench research and clinical application.
